Children and young people with peanut allergy exposed to gradually increasing doses of peanut allergen were then able to ingest far higher doses of peanut protein, a randomised trial has… Click to show full abstract
Children and young people with peanut allergy exposed to gradually increasing doses of peanut allergen were then able to ingest far higher doses of peanut protein, a randomised trial has found. The findings, published in the New England Journal of Medicine ,1 raise hopes that a desensitisation treatment strategy could be developed to reduce the risk of severe fatal reactions that can occur after accidental exposure to allergens. These can be fatal as in the case of Natasha Ednan-Laperouse, who died after eating a baguette from the catering outlet Pret-a-Manger that contained sesame to which she was allergic. The trial, funded by Aimmune Therapeutics, included 551 people aged 4 …
Click one of the above tabs to view related content.